Cannabis Legalization Continues to Influence Consumer Spending

Tuesday, February 6, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

FinancialBuzz.com News Commentary

NEW YORK, February 6, 2018 /PRNewswire/ --

According to Arcview Market

Research, the report estimates that the legal cannabis market will grow from $6.7 billion in consumer spending in 2016 to $22.6 billion in 2021. As a result, the increasing popularity and demand
for the flowers, concentrates, and edibles that the amount needed by cultivators will need to grow. The growth will continue at a 23% compound annual growth rate (CAGR) or from 1.7 million pounds in 2016 to 4.8 million pounds by 2021. On January 1st, California, the most populous state, has started legal sales of recreational products, a development which is projected to significantly push this market forward. The research indicates that the experience so far in smaller states like Colorado, Washington, and Oregon suggests there are major opportunities available even as prices come down. FinCanna Capital Corp. (OTC: FNNZF), Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), Aphria Inc. (OTC: APHQF), Canopy Growth Corporation (OTC: TWMJF), Future Farm Technologies Inc. (OTC: FFRMF)

CEO of The Arcview Group, Troy Dayton, explained, "Aside from cryptocurrency, there is simply no other industry changing as rapidly or as unevenly as the cannabis sector… makes capturing the data, predicting consumer behavior, and forecasting political developments both extraordinarily difficult and complicated, and one of the most vital tools for investors, entrepreneurs, and regulators trying to make sense of it all."

FinCanna Capital Corp. (OTC: FNNZF) also listed on the Canadian Securities Exchange under the trading symbol 'CALI'. Today, the company announced breaking news that it has entered into a royalty agreement with Green Compliance, Inc. ("Green Compliance"). Green Compliance, headquartered in Fort Lauderdale, Florida, offers a state-of-the-art enterprise compliance and point-of-sale software solution ("ezGreen") for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act ("HIPAA") and State Laws by ensuring patients' confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

Green Compliance has commenced sales, and its target market is every licensed operating dispensary and cultivator in States which have passed laws legalizing medical cannabis - currently 29 states and Washington, D.C. Its ezGreen compliance software offers a security and HIPAA compliance strategy for dispensaries operating with valid licenses within their respective States. Most dispensaries use a seed-to-sale solution, and ezGreen has the flexibility to integrate as a plug-in with any existing seed-to-sale software or it can operate as a stand-alone point-of-sale system.

FinCanna CEO, Andriyko Herchak, comments, "We are building a diversified portfolio of royalty investments in companies that have the potential to be the leaders in their respective sectors of the licensed medical cannabis industry. Green Compliance, with its deep-rooted experience in compliance software and medical cannabis industry expertise, is an ideal addition to our royalty portfolio. Green Compliance has already commenced sales, and we expect our royalties to commence in the near future, with a tremendous opportunity for growth across all 29 U.S. states and Washington D.C. which have legalized medical cannabis. "

Green Compliance has an exclusive licensing and support agreement with Automated Healthcare Solutions ("AHCS") to market and sell ezGreen compliance software. AHCS is a leading point of care tracking and dispensing software solution in the U.S. dedicated to the workers compensation vertical in the pharmaceutical industry, and a proven HIPAA compliant solution. AHCS supports thousands of active physicians that dispense medication onsite and has tracked, monitored, reported, and protected patient information for the past 16 years across thousands of physician practices, while maintaining HIPAA compliance and following Health and Human Services protocols in the United States.  

Together, AHCS and Green Compliance developed ezGreen compliance software to offer similar compliance guidelines, standards, and disciplines at the U.S. state level to the licensed medical cannabis industry as is done in the pharmaceutical industry. The ezGreen compliance software includes a suite of tools including state-by-state compliance, tracking, reporting, point-of-sale dispensing and product verification services.  

HIPAA is one of the most significant medical data handling regulation systems in the United States. It has become the template for establishing regulatory requirements for all other industries in regard to handling sensitive patient information.  HIPAA regulations have become more stringent due to the substantial increase in identity theft in recent years. Under the Royalty Agreement, FinCanna will fund US$3 million in the tranches by September 15, 2018. In return, FinCanna will receive a perpetual royalty equal to 10% of consolidated gross revenues of Green Compliance, subject to certain buy-back options.

Green Compliance has also partnered with Chameleon Collective, a strategy-based agency that drives marketing, business development, and innovation across the media, retail, and technology sectors. Chameleon Collective was founded by senior executives, marketers, technologists, entrepreneurs, and change-makers that also have a deep cannabis industry network. Chameleon Collective will help drive marketing, business development and innovation across the media, retail and technology sectors for Green Compliance on a U.S. national level."

FinCanna CEO, Andriyko Herchak, adds, "Partnering with Green Compliance and Chameleon is a very strategic opportunity to increase our presence across the U.S., help fund best-in-class companies and projects, and expand our diversified portfolio of royalty investments.  Excelling at compliance solutions and building strong relationships with its customer base and with regulators will be an effective way for Green Compliance to become a trusted provider and open doors for a number of additional growth opportunities."

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) is a Phase 3 clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. On January 30, 2018, the company announced that it has received a Development Award for up to $25 million from the Cystic Fibrosis Foundation. The Development Award enables the Company to execute its Phase 2b study of its novel, oral, pro-resolving drug lenabasum (formerly known as anabasum) in approximately 415 people with cystic fibrosis  who are 12 years and older and at increased risk for pulmonary exacerbations. Lenabasum (formerly known as anabasum) is a synthetic, oral, small-molecule, selective cannabinoid receptor type 2 (CB2) agonist that preferentially binds to CB2 expressed on activated immune cells and fibroblasts.

Aphria Inc. (OTCQB: APHQF), one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Recently, the company and Liberty Health Sciences Inc. jointly announced that they have entered into a definitive agreement with respect to the sale of Aphria's subsidiary Aphria (Arizona) Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC to Liberty for a purchase price of $20 million. Copperstate owns approximately 1.7 million square feet of greenhouses in Snowflake, Arizona of which approximately 348,000 square feet are in production of medical cannabis.

Canopy Growth Corporation (OTC: TWMJF) is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. On January 25, 2018, the company announced that it has closed the previously announced acquisition of assets and intellectual property from Green Hemp Industrie Ltd. and has welcomed Green's Principal and Founder, Jason Green to the Canopy Growth family. Canopy Growth will combine its own expertise in large-scale cannabinoid extraction processes with Green's unique whole-plant hemp harvesting knowledge and library of stable CBD-rich hemp genetics to position the Company as a global leader in low-cost, high yield CBD production. By diversifying its operations to include hemp harvesting and extraction, the Company will be investing in an innovative new agricultural sector and creating jobs for Saskatchewanians. The field operations alone are ready to scale from 600 acres in 2018 to 2,500 acres in 2019. To support this growth, custom built extraction infrastructure will be installed at Canopy's Tweed Grasslands facility.

Future Farm Technologies Inc. (OTCQB: FFRMF) is a Canadian company with projects throughout North American including California, Florida and Maryland. Recently, the company announced that it has closed on the purchase of a 15,000-sq. ft. building in Providence, Rhode Island. The building is located in a M-1 zone, which legally permits the cultivation of cannabis by right. The Company intends to lease this property to a local, licensed cultivator who will use the property as a licensed medical marijuana cultivation space, providing wholesale cannabis to Rhode Island's state-sanctioned dispensaries. Future Farm is investing heavily in building its portfolio of assets. The Company recently purchased a 10-acre operating greenhouse in Orange County, Florida, which generated an estimated $2,800,000 USD in revenue and $400,000 USD in EBITDA for 2017. It also recently purchased a 120-acre industrial hemp farm and entered into a lease for an additional 100-acres of organic farmland in Maine. The Company also recently entered into a lease agreement for an initial 12,960 sq. ft. of space in a 60,000 sq. ft. building located in Maine, with an option to expand and or buy the building.

Subscribe Now! Watch us report from LIVE https://www.youtube.com/FinancialBuzzMedia  Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz  Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz  Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/  

About FinancialBuzz.com

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For fincanna capital corp. financial news dissemination and PR services, FinancialBuzz.com has been compensated five thousand dollars by the company fincanna capital corp. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com .

Media Contact: info@financialbuzz.com +1-877-601-1879

Url: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store